Literature DB >> 10234004

Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area.

A Bonci1, R C Malenka.   

Abstract

Excitatory inputs to the ventral tegmental area (VTA) influence the activity of both dopaminergic (DA) and GABAergic (GABA) cells, yet little is known about the basic properties of excitatory synapses on these two cell types. Using a midbrain slice preparation and whole-cell recording techniques, we found that excitatory synapses on DA and GABA cells display several differences. Synapses on DA cells exhibit a depression in response to repetitive activation, are minimally affected by the GABAB receptor agonist baclofen, and express NMDA receptor-dependent long-term potentiation (LTP). In contrast, synapses on GABA cells exhibit a facilitation in response to repetitive activation, are depressed significantly by baclofen, and do not express LTP. The relative contribution of NMDA and non-NMDA receptors to the synaptic currents recorded from the two cell types is the same as is the depression of synaptic transmission elicited by the application of adenosine, serotonin, or methionine enkephalin (met-enkephalin). The significant differences in the manner in which excitatory synaptic inputs to DA and GABA cells in the VTA can be modulated have potentially important implications for understanding the behavior of VTA neurons during normal behavior and during pathological states such as addiction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10234004      PMCID: PMC6782740     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  60 in total

Review 1.  NMDA-receptor-independent long-term potentiation.

Authors:  D Johnston; S Williams; D Jaffe; R Gray
Journal:  Annu Rev Physiol       Date:  1992       Impact factor: 19.318

2.  Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus.

Authors:  Z Nusser; R Lujan; G Laube; J D Roberts; E Molnar; P Somogyi
Journal:  Neuron       Date:  1998-09       Impact factor: 17.173

3.  Target cell-specific modulation of transmitter release at terminals from a single axon.

Authors:  M Scanziani; B H Gähwiler; S Charpak
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

Review 4.  Silent synapses speak up.

Authors:  R C Malenka; R A Nicoll
Journal:  Neuron       Date:  1997-09       Impact factor: 17.173

Review 5.  Opioid receptors and the regulation of ion conductances.

Authors:  T J Grudt; J T Williams
Journal:  Rev Neurosci       Date:  1995 Jul-Sep       Impact factor: 4.353

6.  Heterogeneity of release probability, facilitation, and depletion at central synapses.

Authors:  L E Dobrunz; C F Stevens
Journal:  Neuron       Date:  1997-06       Impact factor: 17.173

7.  Target-specific expression of presynaptic mossy fiber plasticity.

Authors:  G Maccaferri; K Tóth; C J McBain
Journal:  Science       Date:  1998-02-27       Impact factor: 47.728

8.  Cocaine inhibits GABA release in the VTA through endogenous 5-HT.

Authors:  D L Cameron; J T Williams
Journal:  J Neurosci       Date:  1994-11       Impact factor: 6.167

9.  DNQX blockade of amphetamine behavioral sensitization.

Authors:  R Karler; L D Calder; S A Turkanis
Journal:  Brain Res       Date:  1991-06-28       Impact factor: 3.252

10.  Sensitization to cocaine's motor activating properties produced by electrical kindling of the medial prefrontal cortex but not of the hippocampus.

Authors:  S Schenk; S Snow
Journal:  Brain Res       Date:  1994-10-03       Impact factor: 3.252

View more
  112 in total

1.  Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use.

Authors:  C W Bradberry
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

2.  Afferent-specific AMPA receptor subunit composition and regulation of synaptic plasticity in midbrain dopamine neurons by abused drugs.

Authors:  Cameron H Good; Carl R Lupica
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 3.  A possible mechanism for the dopamine-evoked synergistic disinhibition of thalamic neurons via the "direct" and "indirect" pathways in the basal ganglia.

Authors:  I G Sil'kis
Journal:  Neurosci Behav Physiol       Date:  2002 May-Jun

Review 4.  Synaptic plasticity in the mesolimbic dopamine system.

Authors:  Mark J Thomas; Robert C Malenka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-04-29       Impact factor: 6.237

Review 5.  Neurotrophic mechanisms in drug addiction.

Authors:  Carlos A Bolaños; Eric J Nestler
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

6.  Presynaptic glycine receptors on GABAergic terminals facilitate discharge of dopaminergic neurons in ventral tegmental area.

Authors:  Jiang-Hong Ye; Fushun Wang; Kresimir Krnjevic; Weizhen Wang; Zhi-Gang Xiong; Jingli Zhang
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

7.  Spike timing-dependent long-term potentiation in ventral tegmental area dopamine cells requires PKC.

Authors:  Percy Luu; Robert C Malenka
Journal:  J Neurophysiol       Date:  2008-04-30       Impact factor: 2.714

8.  Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA.

Authors:  Billy T Chen; M Scott Bowers; Miquel Martin; F Woodward Hopf; Anitra M Guillory; Regina M Carelli; Jonathan K Chou; Antonello Bonci
Journal:  Neuron       Date:  2008-07-31       Impact factor: 17.173

9.  Region-specific changes in the subcellular distribution of AMPA receptor GluR1 subunit in the rat ventral tegmental area after acute or chronic morphine administration.

Authors:  Diane A Lane; Andree A Lessard; June Chan; Eric E O Colago; Yan Zhou; Stefan D Schlussman; Mary Jeanne Kreek; Virginia M Pickel
Journal:  J Neurosci       Date:  2008-09-24       Impact factor: 6.167

Review 10.  Dopaminergic system in birdsong learning and maintenance.

Authors:  Lubica Kubikova; Lubor Kostál
Journal:  J Chem Neuroanat       Date:  2009-11-10       Impact factor: 3.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.